• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧髌骨脱位与α-甘露糖苷酶缺乏症相关。

Bilateral patellar dislocation associated with alpha-mannosidase deficiency.

作者信息

Hale Steven S, Bales Joshua G, Rosenzweig Seth, Daroca Phillip, Bennett James T

机构信息

Department of Orthopaedic Surgery, University of Tennessee, Memphis, Tennessee, USA.

出版信息

J Pediatr Orthop B. 2006 May;15(3):215-9. doi: 10.1097/01.bpb.0000188248.79029.1d.

DOI:10.1097/01.bpb.0000188248.79029.1d
PMID:16601592
Abstract

Mannosidosis is an extremely rare genetic disease characterized by a deficiency of the lysosomal enzyme, alpha-mannosidase. This enzyme is necessary for cleavage of mannose from many glycoproteins. In the absence of this enzyme, mannose accumulates in cells throughout the body, including the joints and the synovium. This disease causes many skeletal changes including dysostosis multiplex, synovial hypertrophy, and Charcot-type joints. We report the case of a girl, aged 9 years and 6 months, who developed bilateral patellar dislocation and severe synovial hypertrophy secondary to alpha-mannosidase deficiency. Her disease was further complicated by Charcot elbow and bilateral hip and elbow avascular necrosis.

摘要

甘露糖苷贮积症是一种极其罕见的遗传性疾病,其特征为溶酶体酶α-甘露糖苷酶缺乏。该酶对于从许多糖蛋白中切割甘露糖是必需的。在缺乏这种酶的情况下,甘露糖会在全身细胞中蓄积,包括关节和滑膜。这种疾病会导致许多骨骼变化,包括多发性骨发育异常、滑膜肥厚和夏科氏关节。我们报告了一例9岁6个月大的女孩病例,该女孩因α-甘露糖苷酶缺乏继发双侧髌骨脱位和严重滑膜肥厚。她的病情因夏科氏肘关节以及双侧髋部和肘部缺血性坏死而进一步复杂化。

相似文献

1
Bilateral patellar dislocation associated with alpha-mannosidase deficiency.双侧髌骨脱位与α-甘露糖苷酶缺乏症相关。
J Pediatr Orthop B. 2006 May;15(3):215-9. doi: 10.1097/01.bpb.0000188248.79029.1d.
2
Destructive joint disease in alpha-mannosidosis. A case report and review of the literature.
Clin Rheumatol. 2004 Feb;23(1):40-2. doi: 10.1007/s10067-003-0770-x. Epub 2003 Nov 13.
3
Bilateral destructive synovitis associated with alpha mannosidase deficiency.与α-甘露糖苷酶缺乏相关的双侧破坏性滑膜炎。
Am J Surg Pathol. 1983 Jul;7(5):487-94. doi: 10.1097/00000478-198307000-00012.
4
Alpha-mannosidosis. Report of a case with morphologic, cytologic and immunohistochemical considerations.α-甘露糖苷贮积症。一例伴有形态学、细胞学及免疫组织化学分析的病例报告。
Acta Cytol. 1994 May-Jun;38(3):441-5.
5
Lysosomal alpha-mannosidase and alpha-mannosidosis.溶酶体α-甘露糖苷酶和α-甘露糖苷贮积症。
Front Biosci (Landmark Ed). 2017 Jan 1;22(1):157-167. doi: 10.2741/4478.
6
Alpha-mannosidosis.α-甘露糖苷贮积症
Orphanet J Rare Dis. 2008 Jul 23;3:21. doi: 10.1186/1750-1172-3-21.
7
Hearing impairment as an early sign of alpha-mannosidosis in children with a mild phenotype: Report of seven new cases.儿童轻度表型α-甘露糖苷贮积症的早期听力障碍:7 例新病例报告。
Am J Med Genet A. 2019 Sep;179(9):1756-1763. doi: 10.1002/ajmg.a.61273. Epub 2019 Jun 26.
8
Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.α-甘露糖苷贮积症豚鼠的酶替代疗法
Mol Genet Metab. 2006 Sep-Oct;89(1-2):48-57. doi: 10.1016/j.ymgme.2006.05.005. Epub 2006 Jun 27.
9
The dislocating patella. Etiology and prognosis in relation to generalized joint laxity and anatomy of the patellar articulation.髌骨脱位。与全身关节松弛及髌骨关节解剖结构相关的病因学及预后
Acta Orthop Scand Suppl. 1983;201:1-53.
10
Cemented total hip arthroplasty in a patient with alpha-mannosidosis: a case report.α-甘露糖苷贮积症患者的骨水泥型全髋关节置换术:病例报告
Hip Int. 2009 Apr-Jun;19(2):151-4. doi: 10.1177/112070000901900213.

引用本文的文献

1
Familial association and epidemilogical factors as risk factors for developing first time and recurrent patella dislocation: a systematic review and best knowledge synthesis of present literature.家族相关性和流行病学因素作为初次和复发性髌骨脱位的风险因素:对现有文献的系统回顾和最佳知识综合。
Knee Surg Sports Traumatol Arthrosc. 2023 Sep;31(9):3701-3733. doi: 10.1007/s00167-022-07265-z. Epub 2023 Jan 11.
2
Alpha-mannosidosis.α-甘露糖苷贮积症
Orphanet J Rare Dis. 2008 Jul 23;3:21. doi: 10.1186/1750-1172-3-21.